[%TAGS (074db819ec% %074db819ec) %]

(074db819ec% subtitle %074db819ec)


(074db819ec%|loc%074db819ec)chronological(074db819ec% END %074db819ec) (074db819ec%|loc%074db819ec)Thread(074db819ec% END %074db819ec) 
(074db819ec% IF user.email && action == 'arc' %074db819ec)
(074db819ec%|loc%074db819ec)Reply to sender(074db819ec%END%074db819ec) (074db819ec%|loc%074db819ec)to list(074db819ec%END%074db819ec)

(074db819ec% IF user.email == 'Laurent Guerby guerby@acm.org' || is_owner %074db819ec) (074db819ec% END %074db819ec)
(074db819ec% END %074db819ec)
Since there has been some discussions about drug patents,
here is an interesting New York Times article:

<http://www.nytimes.com/library/magazine/home/20010128mag-aids.html>

And the Slashdot discussion:

<http://slashdot.org/article.pl?sid=01/01/27/2024245&mode=flat>

-- 
Laurent Guerby <guerby@acm.org>





(074db819ec%|loc%074db819ec)Archive powered by(074db819ec%END%074db819ec) MhonArc 2.6.16.

(074db819ec%TAGS [% %]%074db819ec)